Trial intelligence / Profile preview

Modafinil for Cognitive Functioning in Schizophrenia

NCT00314639Phase 2Completed

Sponsor
Université Laval
Start
Sep 2005
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of modafinil in schizophrenia, schizophrenia spectrum and other psychotic disorders, sponsored by Université Laval. Started Sep 2005; status: completed.

02

Drugs

modafinil
03

Conditions

schizophreniaschizophrenia spectrum and other psychotic disorders

Beyond the preview

Go deeper on NCT00314639.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00314639.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call